… This study evaluates the association between antivirals (Molnupiravir and … -19 patients
during an Omicron outbreak. Two cohorts, Nirmatrelvir-Ritonavir versus control and Molnupiravir …

… We assessed the association of either nirmatrelvir or molnupiravir use with the risks of
hospitalization and death from new Omicron subvariants over 90 days among patients who met …

… analysis exploring the association between treatment with molnupiravir and other clinical …
association between clinical deterioration after hospitalization and treatment with molnupiravir …

… in patients hospitalized for COVID-19 in a real-world clinical practice during the wave of
Omicron … The use of molnupiravir in patients hospitalized for COVID-19 during the dominance of …

… However, while institutionalization was less likely in patients on … the patients on Molnupiravir
and the controls (HR = 0.98; 95% CI: 0.89; 1.06) [31]. Nevertheless, patients on Molnupiravir …

… of molnupiravir therapy for COVID-19 patients. In the current meta-analysis, the risk of mortality
was reduced by 34% among adult patients who received molnupiravir … in patients with low …

… This study evaluates the association between antivirals (Molnupiravir and … patients during
an Omicron outbreak. Methods Two cohorts, Nirmatrelvir-Ritonavir vs. control and Molnupiravir …

… In the case-control design as sensitivity analysis, we used conditional logistic regression to
examine the association of receiving oral antiviral drug treatment with hospitalisation and all-…

… We conducted a randomized, controlled trial of molnupiravir in patients infected with Omicron
variant (ChiCTR2200056817, chictr.org.cn). The protocol was reviewed and approved by …

… trial for COVID-19 patients orally administered with molnupiravir. It is the … molnupiravir on
Omicron variant by using an isolate which was successfully cultured from an infected patient …